Fig. 4From: KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndromeQuantification of KANSL1 gene expression levels by qRT-PCR. The expression level of KANSL1 gene on the patient bearing the t(1;17) (grey bar) was half that observed in the control group (black bar)Back to article page